K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer
1997

K-ras and p53 mutations in lung cancer

Sample size: 159 publication Evidence: moderate

Author Information

Author(s): Y Fukuyama, T Mitsudomi, K Sugio, T Ishida, K Akazawa, K Sugimachi

Primary Institution: Kyushu University

Hypothesis

Are K-ras and p53 mutations independent prognostic indicators in non-small-cell lung cancer?

Conclusion

K-ras and p53 mutations are independent unfavourable prognostic markers, especially in early-stage non-small-cell lung cancer.

Supporting Evidence

  • 11 patients (6.9%) had K-ras mutations.
  • 57 patients (35.8%) had p53 mutations.
  • Ras+ patients had a worse prognosis than ras- patients.
  • P53+ patients had a worse prognosis in early-stage cases.
  • Both mutations were independent prognostic factors according to Cox's model.

Takeaway

This study found that certain gene mutations can make lung cancer worse, especially if the cancer is caught early.

Methodology

The study examined 159 patients for K-ras mutations at codon 12 and p53 mutations in exons 5-8, analyzing their correlation with patient prognosis.

Potential Biases

Potential selection bias as the study included only consecutive patients from a single institution.

Limitations

The study may not account for all genetic factors influencing prognosis due to the focus on only K-ras and p53 mutations.

Participant Demographics

159 Japanese patients, 103 men and 56 women, ages 35 to 82 (median 65 years).

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication